Topics
Glioblastoma | Treatment | Tumor treating fields
Home > Publications > Topics > Glioblastoma > Treatment > Tumor treating fields
Mikic N, Gentilal N, Cao F, Lok E, Wong ET, Ballo M, Glas M,
Miranda PC, Thielscher A, Korshoej AR.
Tumor-treating
fields dosimetry in glioblastoma: Insights into treatment
planning, optimization, and dose-response
relationships.
Neurooncol
Adv. 2024 Mar 2;6(1):vdae032. doi:
10.1093/noajnl/vdae032. PMID:
38560348. Review. ˍ
*Wang J, Du Q, Chen J, Liu J, Gu Z, Wang X, Zhang A, Gao S, Shao
A, Zhang J, Wang Y.
Tumor treating
fields in glioblastoma: long-term treatment and high compliance as
favorable prognostic factors.
Front
Oncol. 2024 Mar 20;14:1345190. doi:
10.3389/fonc.2024.1345190. PMID:
38571508. Observational study. ˍ
Xiang Y, Chen Y, Xu Z, Zhou S, Qin Z, Chen L, Xiao D, Liu
S.
Real-world cost-effectiveness
analysis: Tumor Treating Fields for newly diagnosed glioblastoma
in China.
J
Neurooncol. 2024 Apr 2. doi:
10.1007/s11060-024-04662-x. PMID:
38563851. Observational study˰
ˍ
Lan J, Liu Y, Chen J, Liu H, Feng Y, Liu J, Chen L.
Advanced
tumor electric fields therapy: A review of innovative research and
development and prospect of application in glioblastoma.
CNS
Neurosci Ther. 2024 May 7;30(5):e14720. doi:
10.1111/cns.14720. PMID:
38715344.
Review. ˍ
Goldlust SA, Singer S, Cappello LA, AlMekkawi AK, Lee KD, Ingenito
AC, Lewis BE, Nyirenda T, Azmi H, Kaptain GJ.
Phase
1 study of concomitant tumor treating fields and temozolomide
chemoradiation for newly diagnosed glioblastoma.
Neurooncol
Adv. 2024 Jul 29;6(1):vdae129. doi:
10.1093/noajnl/vdae129. PMID:
39211521. Interventional study.ˍ
Biedermann GB, Merrifield K, Lustgarten L.
Case
report: Safety of Tumor Treating
Fields therapy with an implantable cardiac pacemaker in a patient
with glioblastoma.
Front
Oncol. 2024 Aug 22;14:1441146. doi:
10.3389/fonc.2024.1441146. PMID:
39239269. Case report. ˍ